AVITA Medical, Inc.
RCEL
$10.25
$0.181.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 64.25M | 60.04M | 54.14M | 50.70M | 50.14M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 64.25M | 60.04M | 54.14M | 50.70M | 50.14M |
| Cost of Revenue | 9.09M | 8.61M | 7.53M | 7.63M | 7.78M |
| Gross Profit | 55.16M | 51.43M | 46.61M | 43.07M | 42.36M |
| SG&A Expenses | 91.37M | 88.10M | 80.03M | 72.39M | 65.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -59.00K | -271.00K | -801.00K | -1.43M |
| Total Operating Expenses | 120.82M | 118.93M | 108.53M | 100.64M | 92.79M |
| Operating Income | -56.57M | -58.89M | -54.39M | -49.94M | -42.65M |
| Income Before Tax | -61.79M | -57.27M | -49.74M | -44.75M | -35.32M |
| Income Tax Expenses | 54.00K | 47.00K | 86.00K | 66.00K | 66.00K |
| Earnings from Continuing Operations | -61.85 | -57.32 | -49.83 | -44.82 | -35.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -61.85M | -57.32M | -49.83M | -44.82M | -35.38M |
| EBIT | -56.57M | -58.89M | -54.39M | -49.94M | -42.65M |
| EBITDA | -55.45M | -57.98M | -53.63M | -49.24M | -42.02M |
| EPS Basic | -2.39 | -2.23 | -1.95 | -1.76 | -1.40 |
| Normalized Basic EPS | -1.47 | -1.53 | -1.38 | -1.26 | -1.03 |
| EPS Diluted | -2.39 | -2.23 | -1.95 | -1.76 | -1.40 |
| Normalized Diluted EPS | -1.47 | -1.53 | -1.38 | -1.26 | -1.03 |
| Average Basic Shares Outstanding | 103.53M | 102.86M | 102.28M | 101.76M | 101.32M |
| Average Diluted Shares Outstanding | 103.53M | 102.86M | 102.28M | 101.76M | 101.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |